Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSENTAN vs ENZALUTAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOSENTAN vs ENZALUTAMIDE: Safety Overview

Metric BOSENTAN ENZALUTAMIDE
Total FAERS Reports 19,581 49,270
Deaths Reported 4,346 9,676
Death Rate 22.2% 19.6%
Hospitalizations 8,862 9,282
Average Patient Age 52.5 yrs 76.0 yrs
% Female Patients 73.2% 0.6%
FDA Approval Date Apr 26, 2019 Apr 22, 2022
Manufacturer Actelion Pharmaceuticals US, Inc. Astellas Pharma US, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription